Scilex Holding Company (SCLXW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-23.24 et chiffre d'affaires de $0.06B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-0.56 vs est $-23.24 (dépassé +97.6%). Précision des analystes: 0%.
